Cite
A Fluorescence In situ Hybridization Screen for E26 Transformation–Specific Aberrations: Identification of DDX5-ETV4 Fusion Protein in Prostate Cancer
MLA
Sooryanarayana Varambally, et al. “A Fluorescence In Situ Hybridization Screen for E26 Transformation–Specific Aberrations: Identification of DDX5-ETV4 Fusion Protein in Prostate Cancer.” Cancer Research, vol. 68, Sept. 2008, pp. 7629–37. EBSCOhost, https://doi.org/10.1158/0008-5472.can-08-2014.
APA
Sooryanarayana Varambally, Chandan Kumar-Sinha, Anjana Menon, Nallasivam Palanisamy, Yusong Gong, Rajal B. Shah, Saravana M. Dhanasekaran, Arul M. Chinnaiyan, Bo Han, Sunita Shankar, Scott A. Tomlins, Lei Wang, Rohit Mehra, Robert J. Lonigro, Bharathi Laxman, Jindan Yu, & Xiaosong Wang. (2008). A Fluorescence In situ Hybridization Screen for E26 Transformation–Specific Aberrations: Identification of DDX5-ETV4 Fusion Protein in Prostate Cancer. Cancer Research, 68, 7629–7637. https://doi.org/10.1158/0008-5472.can-08-2014
Chicago
Sooryanarayana Varambally, Chandan Kumar-Sinha, Anjana Menon, Nallasivam Palanisamy, Yusong Gong, Rajal B. Shah, Saravana M. Dhanasekaran, et al. 2008. “A Fluorescence In Situ Hybridization Screen for E26 Transformation–Specific Aberrations: Identification of DDX5-ETV4 Fusion Protein in Prostate Cancer.” Cancer Research 68 (September): 7629–37. doi:10.1158/0008-5472.can-08-2014.